{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:04:48Z","timestamp":1789707888342,"version":"4.0.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extracellular vesicles (EVs) are lipid-delimited particles that mediate intercellular communication and have been implicated in both autoimmune and prothrombotic conditions. Livedo reticularis (LR) is a cutaneous vascular pattern associated with impaired dermal arteriolar blood flow and increased vascular risk, yet the contribution of EVs to LR pathogenesis has not been studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To characterize the procoagulant properties, cellular origin, and proteomic profile of plasma-derived EVs in LR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma-derived EVs were isolated from 12 LR patients and seven healthy controls. Tissue factor (TF) activity, EV concentration, proteomic cargo, and cellular origin were assessed using chromogenic assays, nanoparticle tracking analysis, mass spectrometry, and flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TF activity was significantly increased in LR plasma and was enriched within the small EV fraction. Sequential centrifugation demonstrated a stepwise reduction in TF activity, implicating both large and small EVs as contributors. EV concentrations did not differ between groups, indicating qualitative rather than quantitative differences. Proteomic analysis revealed a distinct EV cargo in LR, with widespread protein downregulation and enrichment of coagulation, vascular homeostasis, and VEGF signaling pathways. Notably, KLF8 was markedly reduced. The composition of cells of origin was different, as EVs from LR patients showed an increased leukocyte-derived and decreased platelet-derived profile.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LR is associated with an EV-driven procoagulant and inflammatory phenotype characterized by TF activity, altered cargo, and immune-cell origin, suggesting a role for EV-mediated thrombo-inflammatory microvascular dysfunction in LR pathogenesis. Abundance of KLF8 is markedly reduced, which renders it a target for further mechanistic research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1940778","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:36:50Z","timestamp":1789706210000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Procoagulant effects of extracellular vesicles in patients with livedo reticularis"],"prefix":"10.3389","volume":"17","author":[{"given":"Avital","family":"Baniel","sequence":"first","affiliation":[{"name":"Department of Dermatology, Veteran Affairs (VA) Medical Center","place":["Philadelphia, PA, United States"]},{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]},{"name":"Dermatology Ward, Tel Aviv Sourasky University Medical Center","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ricco","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Veteran Affairs (VA) Medical Center","place":["Philadelphia, PA, United States"]},{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Dhiman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Veteran Affairs (VA) Medical Center","place":["Philadelphia, PA, United States"]},{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Eldaboush","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Veteran Affairs (VA) Medical Center","place":["Philadelphia, PA, United States"]},{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Stone","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Veteran Affairs (VA) Medical Center","place":["Philadelphia, PA, United States"]},{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Furman","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Veteran Affairs (VA) Medical Center","place":["Philadelphia, PA, United States"]},{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Vijayarangan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darae","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Veteran Affairs (VA) Medical Center","place":["Philadelphia, PA, United States"]},{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Musante","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Fazelinia","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Spruce","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Lin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Veteran Affairs (VA) Medical Center","place":["Philadelphia, PA, United States"]},{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria P.","family":"Werth","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Veteran Affairs (VA) Medical Center","place":["Philadelphia, PA, United States"]},{"name":"Department of Dermatology, University of Pennsylvania (UPENN)","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1055\/a-2595-1811","article-title":"Consensus on the management of the clinical challenges of venous thromboembolism in special situations","volume":"125","author":"Marzo","year":"2025","journal-title":"Thromb Haemost"},{"key":"B3","first-page":"499","article-title":"Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome","volume":"23","author":"Toubi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221126852","article-title":"Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis","volume":"31","author":"Loiseau","year":"2022","journal-title":"Lupus"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(89)80823-x","article-title":"Clinical and immunologic features of livedo reticularis in lupus: a case-control study","volume":"87","author":"Englert","year":"1989","journal-title":"Am J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.0000252898.48084.6a","article-title":"Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes","volume":"27","author":"Chung","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.110.233056","article-title":"Microparticles in hemostasis and thrombosis","volume":"108","author":"Mackman","year":"2011","journal-title":"Circ Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.3390\/cells9051211","article-title":"Characterization of plasma-derived small extracellular vesicles indicates ongoing endothelial and platelet activation in patients with thrombotic antiphospholipid syndrome","volume":"9","author":"\u0160tok","year":"2020","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.100124","article-title":"Tissue factor activity of small and large extracellular vesicles in different diseases","volume":"7","author":"Sachetto","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1172\/jci194715","article-title":"Novel perspectives on extracellular vesicles in autoimmune diseases: immunogenicity, inflammation, and immune surveillance","volume":"136","author":"Zhao","year":"2026","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2026.107605","article-title":"Extracellular vesicles as orchestrators of arterial and venous thrombosis: a unified mechanistic model","volume":"163","author":"Xia","year":"2026","journal-title":"Vascul Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jid.2025.06.1597","article-title":"Dysregulated pathways and potential biomarkers in dermatomyositis plasma-derived extracellular vesicles: a pilot study","volume":"146","author":"Baniel","year":"2026","journal-title":"J Invest Dermatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1055\/s-0037-1599081","article-title":"Extracellular vesicles in the antiphospholipid syndrome","volume":"44","author":"Chaturvedi","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209796","article-title":"KLF8 transcription factor participates in oncogenic transformation","volume":"26","author":"Wang","year":"2007","journal-title":"Oncogene"},{"key":"B15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4196\/kjpp.2017.21.1.37","article-title":"Regulation of vascular smooth muscle phenotype by cross-regulation of Kr\u00fcppel-like factors","volume":"21","author":"Ha","year":"2017","journal-title":"Korean J Physiol Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.148027","article-title":"The Kr\u00fcppel-like factor (KLF) family, diseases, and physiological events","volume":"895","author":"Yuce","year":"2024","journal-title":"Gene"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114351","article-title":"The role of Kr\u00fcppel-like factor 8 in cancer biology: current research and its clinical relevance","volume":"183","author":"Kumar","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35786-6","article-title":"Kr\u00fcppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma","volume":"8","author":"Cheng","year":"2018","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30235","article-title":"KLF8 is activated by TGF-\u03b21 via Smad2 and contributes to ovarian cancer progression","volume":"123","author":"Cherukunnath","year":"2022","journal-title":"J Cell Biochem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-06-4729","article-title":"Kr\u00fcppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx441","article-title":"Kr\u00fcppel-like factors compete for promoters and enhancers to fine-tune transcription","volume":"45","author":"Ilsley","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i27.4309","article-title":"Kr\u00fcppel-like factor 8 overexpression is correlated with angiogenesis and poor prognosis in gastric cancer","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1735191","article-title":"KLF11 protects against venous thrombosis via suppressing tissue factor expression","volume":"122","author":"Liang","year":"2022","journal-title":"Thromb Haemost"},{"key":"B24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.m113.035600","article-title":"Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics","volume":"13","author":"Ilsley","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6522","DOI":"10.1038\/s41598-017-03262-2","article-title":"Different potential of extracellular vesicles to support thrombin generation: contributions of phosphatidylserine, tissue factor, and cellular origin","volume":"7","author":"Fagerberg","year":"2017","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1940778\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:36:53Z","timestamp":1789706213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1940778\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2026.1940778"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1940778","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1940778"}}